Healthcare provider profile · identity verified

Heather R Krueger, MD

Family Practice · LAKEVILLE, MN · NPI 1609868280

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	316	96
Levothyroxine Sodium	Levothyroxine Sodium	291	78
Lisinopril	Lisinopril	289	75
Simvastatin	Simvastatin	192	56
Metoprolol Succinate	Metoprolol Succinate	152	40
Omeprazole	Omeprazole	152	48
Amlodipine Besylate	Amlodipine Besylate	151	51
Losartan Potassium	Losartan Potassium	128	35
Pantoprazole Sodium	Pantoprazole Sodium	126	35
Oxycodone Hcl	Oxycodone Hcl	118	11
Hydrochlorothiazide	Hydrochlorothiazide	107	33
Metformin Hcl	Metformin Hcl	101	26
Rosuvastatin Calcium	Rosuvastatin Calcium	100	26
Gabapentin	Gabapentin	95	29
Raloxifene Hcl	Raloxifene Hcl	87	21
Clonazepam	Clonazepam	82	14
Albuterol Sulfate Hfa	Albuterol Sulfate	79	36
Duloxetine Hcl	Duloxetine Hcl	75	20
Sertraline Hcl	Sertraline Hcl	75	21
Trazodone Hcl	Trazodone Hcl	72	23
Bupropion Xl	Bupropion Hcl	69	20
Famotidine	Famotidine	67	20
Escitalopram Oxalate	Escitalopram Oxalate	66	27
Citalopram Hbr	Citalopram Hydrobromide	61	18
Fluoxetine Hcl	Fluoxetine Hcl	61	15
Tizanidine Hcl	Tizanidine Hcl	60	15
Furosemide	Furosemide	59	22
Metoprolol Tartrate	Metoprolol Tartrate	59	13
Spironolactone	Spironolactone	59	16
Carvedilol	Carvedilol	56	12
Alendronate Sodium	Alendronate Sodium	54	15
Alprazolam	Alprazolam	54	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	14
Montelukast Sodium	Montelukast Sodium	54	16
Estradiol	Estradiol	52	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	52	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	11
Tamsulosin Hcl	Tamsulosin Hcl	45	12
Tramadol Hcl	Tramadol Hcl	43	suppressed
Methocarbamol	Methocarbamol	38	15
Ozempic	Semaglutide	38	suppressed
Prednisone	Prednisone	36	22
Allopurinol	Allopurinol	35	11
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Glimepiride	Glimepiride	32	suppressed
Metformin Hcl Er	Metformin Hcl	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	19
Celecoxib	Celecoxib	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Jardiance	Empagliflozin	30	suppressed
Aripiprazole	Aripiprazole	29	suppressed
Atenolol	Atenolol	29	suppressed
Eliquis	Apixaban	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	15
Mirtazapine	Mirtazapine	28	suppressed
Pregabalin	Pregabalin	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Fentanyl	Fentanyl	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Lorazepam	Lorazepam	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	11
Ezetimibe	Ezetimibe	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Jantoven	Warfarin Sodium	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Baclofen	Baclofen	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	18	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Premarin	Estrogens, Conjugated	16	suppressed
Atrovent Hfa	Ipratropium Bromide	15	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Irbesartan	Irbesartan	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Eletriptan Hbr	Eletriptan Hydrobromide	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Glipizide	Glipizide	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Yuvafem	Estradiol	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error